| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 19 Feb 25 | PTPI Petros Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 1,000,000 | 0.00 | 1,011,237 |
| 2 Dec 24 | AYRO Ayro | Common Stock | Grant | Acquire A | No | No | 0 | 146,052 | 0.00 | 189,323 |
| 2 Dec 24 | AYRO Ayro | Common Stock | Sale back to company | Dispose D | No | No | 0 | 6,166 | 0.00 | 43,271 |
| 2 Dec 24 | AYRO Ayro | RSU Common Stock | Option exercise | Acquire M | No | No | 0 | 97,368 | 0.00 | 97,368 |
| 12 Jul 24 | FEMY Femasys | Stock Option Common Stock | Grant | Acquire A | No | No | 1.14 | 17,600 | 20.06 k | 17,600 |
| 8 Apr 24 | SNPX Synaptogenix | Stock Option Common Stock, par value $0.0001 per share | Grant | Acquire A | No | No | 5.39 | 800 | 4.31 k | 800 |
| 21 Dec 23 | PTPI Petros Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 1.41 | 40,000 | 56.40 k | 40,000 |
